The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Frontline treatment with zanubrutinib plus rituximab (ZR) followed by short course R-DHAOx in patients with mantle cell lymphoma (MCL): Results of the phase II CHESS clinical trial.
 
Qingqing Cai
No Relationships to Disclose
 
Yi Xia
No Relationships to Disclose
 
Huiqiang Huang
No Relationships to Disclose
 
Zhiming Li
No Relationships to Disclose
 
He Huang
No Relationships to Disclose
 
Guowei Li
No Relationships to Disclose
 
Yuchen Zhang
No Relationships to Disclose
 
Yi Cao
No Relationships to Disclose
 
Yan Gao
No Relationships to Disclose
 
PanPan Liu
No Relationships to Disclose
 
Xiaojie Fang
No Relationships to Disclose
 
Man Mie
No Relationships to Disclose
 
Xiaopeng Tian
No Relationships to Disclose
 
Xiuhua Sun
No Relationships to Disclose
 
Xueyi Pan
No Relationships to Disclose